Biosig Technologies, Common Stock Performance
| BSGM Stock | USD 0.49 0.06 10.91% |
The firm shows a Beta (market volatility) of -2.31, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning BioSig Technologies, are expected to decrease by larger amounts. On the other hand, during market turmoil, BioSig Technologies, is expected to outperform it. At this point, BioSig Technologies, has a negative expected return of -1.42%. Please make sure to confirm BioSig Technologies,'s value at risk and the relationship between the accumulation distribution and relative strength index , to decide if BioSig Technologies, performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days BioSig Technologies, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 357 K |
BioSig |
BioSig Technologies, Relative Risk vs. Return Landscape
If you would invest 143.00 in BioSig Technologies, Common on December 26, 2024 and sell it today you would lose (94.00) from holding BioSig Technologies, Common or give up 65.73% of portfolio value over 90 days. BioSig Technologies, Common is currently does not generate positive expected returns and assumes 8.3948% risk (volatility on return distribution) over the 90 days horizon. In different words, 74% of otc stocks are less volatile than BioSig, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioSig Technologies, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioSig Technologies,'s investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as BioSig Technologies, Common, and traders can use it to determine the average amount a BioSig Technologies,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1694
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BSGM |
Estimated Market Risk
| 8.39 actual daily | 74 74% of assets are less volatile |
Expected Return
| -1.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioSig Technologies, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioSig Technologies, by adding BioSig Technologies, to a well-diversified portfolio.
BioSig Technologies, Fundamentals Growth
BioSig OTC Stock prices reflect investors' perceptions of the future prospects and financial health of BioSig Technologies,, and BioSig Technologies, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioSig OTC Stock performance.
| Return On Equity | -59.77 | ||||
| Return On Asset | -4.48 | ||||
| Operating Margin | (227.43) % | ||||
| Current Valuation | 6.43 M | ||||
| Shares Outstanding | 14.12 M | ||||
| Price To Earning | (3.73) X | ||||
| Price To Book | 36.58 X | ||||
| Price To Sales | 90.04 X | ||||
| Revenue | 18 K | ||||
| EBITDA | (28.15 M) | ||||
| Cash And Equivalents | 887 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 452 K | ||||
| Debt To Equity | 0.45 % | ||||
| Book Value Per Share | (0.39) X | ||||
| Cash Flow From Operations | (17.31 M) | ||||
| Earnings Per Share | (0.86) X | ||||
| Total Asset | 1.8 M | ||||
| Retained Earnings | (245.01 M) | ||||
| Current Asset | 984.54 K | ||||
| Current Liabilities | 2.47 M | ||||
About BioSig Technologies, Performance
By examining BioSig Technologies,'s fundamental ratios, stakeholders can obtain critical insights into BioSig Technologies,'s financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that BioSig Technologies, is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.Things to note about BioSig Technologies, performance evaluation
Checking the ongoing alerts about BioSig Technologies, for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for BioSig Technologies, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioSig Technologies, generated a negative expected return over the last 90 days | |
| BioSig Technologies, has high historical volatility and very poor performance | |
| BioSig Technologies, has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K. | |
| BioSig Technologies, Common currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders |
- Analyzing BioSig Technologies,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioSig Technologies,'s stock is overvalued or undervalued compared to its peers.
- Examining BioSig Technologies,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioSig Technologies,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioSig Technologies,'s management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of BioSig Technologies,'s otc stock. These opinions can provide insight into BioSig Technologies,'s potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.